Inventor · disambiguated record
Guoping Hu
Also filed as: HU GUOPING
32 granted patents·12 pending applications·27 citations·filing 2015–2024
94Inventor score
Files withMEDSHINE DISCOVERY INC14CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD8ZHUHAI UNITED LABORATORIES CO LTD5GUANGDONG RAYNOVENT BIOTECH CO LTD2CHANGZHOU YINSHENG PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
44 records- 0187US10519133B2Vinyl compounds as FGFR and VEGFR inhibitorsMEDSHINE DISCOVERY INC·Filed 2016·Granted Dec 31, 2019·4 cites·16 claims
- 0286US11932617B2Compound for use in retinal diseasesZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 19, 2024·3 cites·6 claims
- 0380US11919896B2[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 5, 2024·2 cites·19 claims
- 0480US11453667B2Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted Sep 27, 2022·2 cites·19 claims
- 0579US11623923B2Uracil compound as c-MET/AXL inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Apr 11, 2023·2 cites·23 claims
- 0679US11358950B2SMAC mimetics used as IAP inhibitors and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jun 14, 2022·2 cites·19 claims
- 0778US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
- 0876US10548883B2Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitorGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2017·Granted Feb 4, 2020·1 cites·19 claims
- 0974US11377444B2Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitorsMEDSHINE DISCOVERY INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 1074US10662174B2BTK inhibitorHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2017·Granted May 26, 2020·1 cites·8 claims
- 1173US11008292B2FGFR4 inhibitor and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2017·Granted May 18, 2021·1 cites·15 claims
- 1272US12221432B2Estrogen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Feb 11, 2025·1 cites·20 claims
- 1371US10662189B2PDE4 inhibitorSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2017·Granted May 26, 2020·1 cites·31 claims
- 1471US10532986B2Cyclic compound acting as PDE4 inhibitorMEDSHINE DISCOVERY INC·Filed 2017·Granted Jan 14, 2020·1 cites·24 claims
- 1569US12479823B2Compound for use in retinal diseasesZHUHAI UNITED LABORATORIES CO LTD·Filed 2024·Granted Nov 25, 2025·0 cites·12 claims
- 1668US10654808B2Tyrosine kinase inhibitor and pharmaceutical composition comprising sameGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 19, 2020·1 cites·21 claims
- 1767US10035792B2Resorcinol derivative as HSP90 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jul 31, 2018·1 cites·20 claims
- 1860US12473258B2Crystal form of pyridinylphenyl compound and preparation method thereforZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Nov 18, 2025·0 cites·20 claims
- 1960US11655248B2Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2021·Granted May 23, 2023·0 cites·18 claims
- 2057US2024270810A1Preparation and application of polypeptideGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2156US11130761B2Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitorsCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2017·Granted Sep 28, 2021·0 cites·20 claims
- 2256US2024158413A1Fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compound and use thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
- 2354US2023357272A1Octahydropyrazinodiazanaphthyridine dione compoundsMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 2452US12415799B2Indazole-fused cyclic compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Sep 16, 2025·0 cites·11 claims
- 2552US11427581B2JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 2652US2023017539A1Tri-heterocyclic compound as jak inhibitor, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 2751US11739090B2Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitorsJUMBO DRUG BANK CO LTD·Filed 2020·Granted Aug 29, 2023·0 cites·16 claims
- 2850US11236107B2Crystal of tricyclic compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·20 claims
- 2950US2022281868A1Macrocyclic derivatives as factor xia inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3050US2024190861A1Aminopyrimidine compound as cdk2/4/6 triple inhibitorCISEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3149US12351590B2Pyrrolopyrimidine compound and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·17 claims
- 3249US2023055321A1Pyrimidopyrrole spiro compounds and derivatives thereof as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3349US2024067702A1Lactam-modified polypeptide compoundsDONGBAO PURPLE STAR HANGZHOU BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3448US2023026616A1Pyrimidoimidazole compounds used as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3548US2024109861A1Series of piperidine-substituted benzoic acid compounds, and use thereofMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3647US2022119431A1Salt of egfr inhibitor, crystal form, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 3743US11390625B2Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 19, 2022·0 cites·16 claims
- 3843US10501443B2Pyridone compound as c-met inhibitorFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 10, 2019·0 cites·17 claims
- 3941US10617690B2JAK inhibitorWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 14, 2020·0 cites·27 claims
- 4040US10508103B2Benzimidazole-linked indole compound acting as novel divalent IAP antagonistMEDSHINE DISCOVERY INC·Filed 2017·Granted Dec 17, 2019·0 cites·32 claims
- 4139US11639355B2Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted May 2, 2023·0 cites·15 claims
- 4239US10487088B2Tricyclic compound serving as immunomodulatorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Nov 26, 2019·0 cites·19 claims
- 4336US10160771B2Hepatitis C virus inhibitors and uses thereof in preparation of drugsCHANGZHOU YINSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 25, 2018·0 cites·7 claims
- 4433US2018148452A1Toll-like receptor-7 agonistMEDSHINE DISCOVERY INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guoping Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →